artelac 3.20mg/ ml ophthalmic solution (drops)
bausch & lomb philippines inc.; distributor: bausch & lomb philippines inc. - methylhydroxypropylcellulose - ophthalmic solution (drops) - 3.20mg/ ml
methocel 2 per cent
dispersa (uk) ltd - methylhydroxypropylcellulose - 2 per cent
zofran
novartis new zealand ltd - ondansetron hydrochloride dihydrate 4mg - tablet - 4 mg - active: ondansetron hydrochloride dihydrate 4mg excipient: hypromellose lactose magnesium stearate microcrystalline cellulose opaspray yellow m-1-8429 pregelatinised maize starch - zofran tablets, zofran solution for injection and zofran zydis wafers are indicated for: · management of nausea and vomiting induced by cytotoxic chemotherapy in children, adolescents and adults. · management of nausea and vomiting induced by radiotherapy in adults. zofran solution for injection is also indicated for: · prevention of post-operative nausea and vomiting in children, adolescents and adults. studies have not be conducted on the use of zofran tablets or zofran zydis wafers in the prevention of post-operative nausea and vomiting in the paediatric population.
zofran
novartis new zealand ltd - ondansetron hydrochloride dihydrate 8mg - tablet - 8 mg - active: ondansetron hydrochloride dihydrate 8mg excipient: hypromellose lactose magnesium stearate microcrystalline cellulose opaspray yellow m-1-8429 pregelatinised maize starch - zofran tablets, zofran solution for injection and zofran zydis wafers are indicated for: · management of nausea and vomiting induced by cytotoxic chemotherapy in children, adolescents and adults. · management of nausea and vomiting induced by radiotherapy in adults. zofran solution for injection is also indicated for: · prevention of post-operative nausea and vomiting in children, adolescents and adults. studies have not be conducted on the use of zofran tablets or zofran zydis wafers in the prevention of post-operative nausea and vomiting in the paediatric population.
naramig tablets 2.5 mg
glaxo smith kline (israel) ltd - naratriptan as hydrochloride - film coated tablets - naratriptan as hydrochloride 2.5 mg - naratriptan - naratriptan - naramig tablets are indicated for the acute treatment of migraine attacks with or without aura.
caltrate 600 mg/400 iu, film-coated tablets
pfizer healthcare ireland - calcium carbonate; cholecalciferol concentrate - film-coated tablet - 600 mg/400 international unit(s) - calcium, combinations with vitamin d and/or other drugs
xatral 2.5mg film-coated tablets
ltt pharma limited - alfuzosin hydrochloride - film-coated tablet - 2.5 milligram(s) - alpha-adrenoreceptor antagonists; alfuzosin
naramig tablets 2.5 mg
glaxosmithkline pte ltd - naratriptan hydrochloride 2.78 mg eqv naratriptan - tablet, film coated - 2.5 mg - naratriptan hydrochloride 2.78 mg eqv naratriptan 2.5 mg
tritace 2.5 tablet 2.5 mg
sanofi-aventis singapore pte. ltd. - ramipril - tablet - 2.5 mg - ramipril 2.5 mg
tritace 5 tablet 5 mg
sanofi-aventis singapore pte. ltd. - ramipril - tablet - 5 mg - ramipril 5 mg